Back to search

Agena Bioscience GmbH

6 contracts won£5,201,105,308 total value

Every public sector contract Agena Bioscience GmbH has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Agena Bioscience GmbH for you, and alerts you the moment a renewal goes live.

Where they win

The sectors, tender types and buyers where Agena Bioscience GmbH wins most often.

See every live council tenders and find your next contract before they do.

See all NHS buyers and UK contract awards.

Sectors

Healthcare & Medical4
Goods & Supplies3
Facilities Management1
Architecture & Design1
Research & Consultancy1
Data & Digital Services1

Top Buyers

Cardiff and Vale University Health Board
1 contract
£132,573
Manchester University NHS Foundation Trust
1 contract
£158,325
MHRA
1 contract
MHRA Buyer Organisation
1 contract
£286,000
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
1 contract
£5,200,000,000
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
1 contract
£528,410

Awards(6)

Sort:

UKHSA Diagnostics & Research Open Framework

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
London
£5,200,000,000
Awarded 3 Sept 2026
Ends 27 Sept 2028

PROVISION OF DYPD KITS – MASS ARRAY

Cardiff and Vale University Health Board
Cardiff
£132,573
Awarded 1 Dec 2025
Ends 31 Dec 2028

Genetics MassArray consumables

The Newcastle Upon Tyne Hospitals NHS Foundation Trust
NEWCASTLE UPON TYNE
£528,410
Awarded 31 Jan 2025

VEAT Notice for the Provision of iPLEX Pro Reagent And SpectroCHIP Kit

Manchester University NHS Foundation Trust
MANCHESTER
€158,325
Awarded 2 Dec 2024

Purchase of Mass Array

MHRA
London
Not specified
Awarded 25 Jan 2023

Purchase of a mid-throughput DNA genotyping analysis system

MHRA Buyer Organisation
London
£286,000
Awarded 25 Jan 2023
Ends 20 Jan 2028

Know when Agena Bioscience GmbH's contracts come up for renewal

Business predicts when each of these contracts is due to be re-tendered, follows Agena Bioscience GmbH for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.

Why track Agena Bioscience GmbH?

Agena Bioscience GmbH is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.

How renewal tracking works

We aggregate Agena Bioscience GmbH's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.

What you can do here

  • Review the full history. Every contract Agena Bioscience GmbH has won, with the buyer, value and dates for each.
  • Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
  • Track and get alerted. Follow Agena Bioscience GmbH and be notified when their contracts come up again (Business).
  • Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.

Frequently asked questions

Where does this data come from?

Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.

Is the contract history free?

Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.

How do you predict renewals?

From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.